Brief: Biocept Says Trading Of Common Stock Will Be Suspended By Nasdaq At Opening Of Business On Oct 25
Oct 20 (Reuters) - Biocept Inc BIOC.O :
* BIOCEPT INC - ON OCTOBER 16 RECEIVED NOTICE OF DELISTING
OR
FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD FROM
NASDAQ
* BIOCEPT INC - DOES NOT INTEND TO APPEAL NASDAQ
DETERMINATION
* BIOCEPT INC - TRADING OF COMMON STOCK WILL BE SUSPENDED BY
NASDAQ AT OPENING OF BUSINESS ON OCTOBER 25, 2023
Further company coverage: BIOC.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Biocept
See all newsBrief: Biocept Says Trading Of Common Stock Will Be Suspended By Nasdaq At Opening Of Business On Oct 25
U.S. STOCKS ON THE MOVE-Overstock.com, Biocept, Birkenstock
Biocept slumps after filing for bankruptcy protection
Brief: Biocept CEO Antonino Morales Resigns
U.S. STOCKS ON THE MOVE-Albemarle, Novavax, WeWork